Table 1.
Summary of Point-Prevalence Survey Results from Intensive Care Units, Long-Term Acute Care Hospitals, and Ventilator-Capable Skilled Nursing Facilities for Surveys 1, 2, 3, and 4
| Variable | Intensive Care Unit | Long-Term Acute Care Hospital | Ventilator-Capable Skilled Nursing Facility |
|---|---|---|---|
| Number of surveys | 1 | 4 | 4 |
| Number of facilities | 20 | 7 | 8 |
| Number of patients eligible | 238 | 1338 | 1325 |
| Number of patients surveyed, n (% of eligible) | 212 (89) | 1188 (89) | 1154 (87) |
| Age, mean (standard deviation), y | 62 (17) | 62 (15) | 60 (15) |
| Male, n (%) | 119 (56) | 644 (54) | 627 (54) |
| Length of stay, median (interquartile range), d | 5 (3–10) | 21 (11–37) | 126 (33–410) |
| Mechanical ventilation, n (%) | 102 (48) | 405 (21) | 477 (33) |
| Tracheostomy collar, n (%) | 0 (0) | 250 (21) | 384 (33) |
| Contact precautions, n (%) | 58 (27) | 736 (62) | 679 (59) |
| Carbapenemase gene | |||
| Klebsiella pneumoniae carbapenemase, n (%) | 11 (5) | 182 (15) | 360 (31) |
| New Delhi metallo-beta-lactamase, n (%) | 2 (1) | 30 (3) | 146 (13) |
| OXA-48, n (%) | 1 (0) | 0 (0) | 1 (0) |
| IMP, n (%) | 0 (0) | 1 (0) | 0 (0) |
| VIM, n (%) | 0 (0) | 4 (0) | 66 (6) |
| Any carbapenemase gene, n (%) | 14 (7) | 201 (17) | 479 (42) |
| Of carbapenemase-positive | |||
| With contact precautions, n/N (%) | 9/14 (64) | 169/201 (84) | 364/479 (76) |
| Known to facility, n/N (%) | 6/14 (43) | 107/201 (53) | 303/479 (63) |